Professor John Wilding: SGLT2 inhibition – a novel strategy to improve type 2 diabetes, cardiovascular & renal outcome


100/100

Production and streaming of this multimedia archive
is made possible by the kind support of

© Copyright At the Limits Limited 2005 – 2016
Array ( [0] => WP_Term Object ( [term_id] => 359 [name] => CDNATL019 [slug] => cdnatl019 [term_group] => 0 [term_taxonomy_id] => 363 [taxonomy] => jobnumbers [description] => [parent] => 0 [count] => 55 [filter] => raw ) ) !!7222!!